Skip to content
ACR2021 - Day5a episode artwork

EPISODE · Nov 10, 2021 · 28 MIN

ACR2021 - Day5a

from Rheumnow Podcast · host Dr. Cush

Tofacitinib and Malignancy Risk: Dr. Seoyoung Kim Potpourri of Biosimilar Trials: Dr. Jonathan Kay Closing a Chapter: Interview with the 84th ACR President 2020-2021, Kathryn Dao

Episode metadata supplied by the publisher feed · Published Nov 10, 2021

Embed this episode

Ready to play

ACR2021 - Day5a

0:00 28:44

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Rheumnow Podcast?

This episode is 28 minutes long.

When was this Rheumnow Podcast episode published?

This episode was published on November 10, 2021.

Can I download this Rheumnow Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!